
Keywords: AASA; aminoadipic semialdehyde; AGE; advanced glycation endproduct; AOPP; advanced oxidation protein product; AQC; 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate; BUL; bilateral ureteral ligation; BNX; bilateral nephrectomy; CEL; Nε-(1-carboxyethyl)lysi